DK187186D0 - N-indolylethyl-sulfonsyreamider, deres fremstilling og anvendelse - Google Patents

N-indolylethyl-sulfonsyreamider, deres fremstilling og anvendelse

Info

Publication number
DK187186D0
DK187186D0 DK187186A DK187186A DK187186D0 DK 187186 D0 DK187186 D0 DK 187186D0 DK 187186 A DK187186 A DK 187186A DK 187186 A DK187186 A DK 187186A DK 187186 D0 DK187186 D0 DK 187186D0
Authority
DK
Denmark
Prior art keywords
indolylethyl
acid amides
sulphonic acid
preparation
thromboembolisms
Prior art date
Application number
DK187186A
Other languages
English (en)
Other versions
DK187186A (da
Inventor
H Boeshagen
U Rosentreter
F Seuter
E Perzborn
V-B Fiedler
F Lieb
H Oediger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK187186D0 publication Critical patent/DK187186D0/da
Publication of DK187186A publication Critical patent/DK187186A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
DK187186A 1985-04-24 1986-04-23 N-indolylethyl-sulfonsyreamider, deres fremstilling og anvendelse DK187186A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853514696 DE3514696A1 (de) 1985-04-24 1985-04-24 N-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung
DE3514696 1985-04-24

Publications (2)

Publication Number Publication Date
DK187186D0 true DK187186D0 (da) 1986-04-23
DK187186A DK187186A (da) 1986-10-25

Family

ID=6268925

Family Applications (1)

Application Number Title Priority Date Filing Date
DK187186A DK187186A (da) 1985-04-24 1986-04-23 N-indolylethyl-sulfonsyreamider, deres fremstilling og anvendelse

Country Status (18)

Country Link
US (1) US4774240A (da)
EP (1) EP0201735B1 (da)
JP (1) JPH0625104B2 (da)
KR (1) KR930011299B1 (da)
CN (1) CN1015054B (da)
AT (1) ATE56433T1 (da)
AU (1) AU590267B2 (da)
CA (1) CA1321585C (da)
DE (2) DE3514696A1 (da)
DK (1) DK187186A (da)
ES (1) ES8802381A1 (da)
FI (1) FI82036C (da)
GR (1) GR861058B (da)
HU (1) HU195483B (da)
IL (1) IL78557A0 (da)
NO (1) NO167283C (da)
PT (1) PT82442B (da)
ZA (1) ZA863028B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
DE3840338A1 (de) * 1988-11-30 1990-05-31 Bayer Ag Neue 2-halogensubstituierte n-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5153214A (en) * 1989-06-28 1992-10-06 Ciba-Geigy Corporation Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
US5025025A (en) * 1989-06-28 1991-06-18 Ciba-Geigy Corporation (Arylsulfonamido- and pyridyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
GB9008108D0 (en) * 1990-04-10 1990-06-06 Bayer Ag Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles
KR100215627B1 (ko) * 1990-06-07 1999-08-16 레슬리 제인 에드워즈 치료용 헤테로사이클 화합물
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US7605156B2 (en) * 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
PL373043A1 (en) * 2002-03-26 2005-08-08 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2003097598A1 (en) 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Compound exhibiting pgd 2 receptor antagonism
JP4619786B2 (ja) * 2002-08-29 2011-01-26 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 炎症性、アレルギー性及び増殖性疾患の治療において糖質コルチコイドミメティックスとして使用するための3−(スルホンアミドエチル)−インドール誘導体
UY28526A1 (es) * 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US7754755B2 (en) * 2004-09-23 2010-07-13 Bristol-Myers Squibb Company Inhibitors of 15-lipoxygenase
CA2584413A1 (en) * 2004-10-29 2006-05-04 Astrazeneca Ab Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
US7635711B2 (en) * 2004-12-27 2009-12-22 Boehringer-Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
TW200829578A (en) 2006-11-23 2008-07-16 Astrazeneca Ab Chemical compounds 537
MX2009005264A (es) * 2006-12-06 2009-05-28 Boehringer Ingelheim Int Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
JO2754B1 (en) 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
US7750027B2 (en) * 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
TWI445705B (zh) 2008-05-20 2014-07-21 Astrazeneca Ab 經苯基及苯并二基取代之吲唑衍生物
ATE541846T1 (de) * 2008-06-06 2012-02-15 Boehringer Ingelheim Int Glucocorticoidmimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und anwendungen davon
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
CN105399697A (zh) * 2014-09-12 2016-03-16 苏州旺山旺水生物医药有限公司 一种氨基磺酰基类化合物、其制备方法及用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs

Also Published As

Publication number Publication date
PT82442A (en) 1986-05-01
FI82036B (fi) 1990-09-28
IL78557A0 (en) 1986-08-31
ATE56433T1 (de) 1990-09-15
EP0201735A1 (de) 1986-11-20
NO167283C (no) 1991-10-23
DE3514696A1 (de) 1986-11-06
US4774240A (en) 1988-09-27
KR930011299B1 (ko) 1993-11-29
HU195483B (en) 1988-05-30
DK187186A (da) 1986-10-25
JPS61249960A (ja) 1986-11-07
KR860008137A (ko) 1986-11-12
NO167283B (no) 1991-07-15
CN86102761A (zh) 1987-02-25
PT82442B (pt) 1988-11-30
FI861683A0 (fi) 1986-04-22
HUT41385A (en) 1987-04-28
AU590267B2 (en) 1989-11-02
AU5672686A (en) 1986-10-30
ZA863028B (en) 1987-12-30
GR861058B (en) 1986-08-19
NO861366L (no) 1986-10-27
DE3674059D1 (de) 1990-10-18
EP0201735B1 (de) 1990-09-12
CN1015054B (zh) 1991-12-11
ES554285A0 (es) 1988-05-16
CA1321585C (en) 1993-08-24
FI861683A7 (fi) 1986-10-25
FI82036C (fi) 1991-01-10
JPH0625104B2 (ja) 1994-04-06
ES8802381A1 (es) 1988-05-16

Similar Documents

Publication Publication Date Title
FI861683A0 (fi) N-indolyletyl-sulfonsyra-amider, foerfarande foer deras framstaellning och deras anvaendning.
NO179867C (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidler
DK379787A (da) Hetrazepiner og fremgangsmaade til deres fremstilling
DK198487A (da) N-(2'-amonophenyl)-benzamid-derivater, fremgangsmaade til deres fremstilling og deres anvendelse til bekaempelse af neoplastiske sygdomme
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
ATE163012T1 (de) N-substituierte 4-pyrimidinamine und - pyrimidindiamine, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel
SE8503207L (sv) Farmakologiskt aktiva substituerade bensamider
SE8301008L (sv) Pyrrolacetamider med antiinflammatorisk verkan
DK163287A (da) 1,4-diazepiner og farmaceutiske midler med indhold af saadanne forbindelser
HK72592A (en) Substituted benzamide
NO881308D0 (no) Dihydropyridinamider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
DK469687D0 (da) Derivater af 4,5-dihydrooxazoler og fremgangsmaade til fremstilling af saadanne derivater.
KR880007070A (ko) 백내장 치료용 약학 조성물
ES8609307A1 (es) 1,4-dihidropiridinas
FI942468A0 (fi) Kemialliset yhdisteet, niiden valmistus ja käyttö
BR9911615A (pt) 2-aminopiridinas contendo substituintes de anel fundido como inibidores de sintase de óxido nìtrico
IE860987L (en) Triazole derivatives
ATE44875T1 (de) 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln.
DK282886D0 (da) Leukotrienantagonist og farmaceutisk praeparat indeholdende en saadan forbindelse
DK0571511T3 (da) Nye urea- og thioureaforbindelser, deres fremstilling og terapeutiske anvendelse
DK102084A (da) N-(3-trifluormethylphenyl)-n'-propargylpiperazin, dets fremstilling og anvendelse
ES2121071T3 (es) Compuestos de oxazolidina y su empleo como medicamentos.
ATE31925T1 (de) 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide.

Legal Events

Date Code Title Description
ATS Application withdrawn